retatrutide trial duration Lilly orforglipron oral GLP-1 phase 3 weight loss Retatrutide Availability & Timeline |

As of the time of writing, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

You can restrict calories in an inflamed body and fight the biology the entire time

Simultaneous GLP-1, GIP, and glucagon receptor activity may help clarify how endocrine pathways coordinate metabolic responses

Others find a once-weekly injection simpler than remembering a daily medication

Over-the-counter medications can target specific side effects, such as nausea, vomiting, or constipation

This positions Mounjaro as a potential game changer